Interested in a strategic partnership?
Welcome to G4 Insights
A scientific intelligence hub that connects the biology and chemistry of G-quadruplex (G4) to diseases, biotechnologies, and future therapeutics.
What is G4 Insights?
G4 Insights is a biweekly curated digital newsletter delivering the latest developments in G-quadruplex biology, disease research, and therapeutic innovation directly to your inbox.
Each issue features:
- High-impact scientific publications
- Industry and drug-development updates
- Conference/events highlights
- Community spotlights
- Selected paper for deep analysis
- Emerging controversies stories
- Key trends shaping the future of G4 research
You'll also receive the G4 Insights Annual Report, which delivers a comprehensive G4 review of the year's most important scientific discoveries, therapeutic advances, technology developments, and industry updates.
Who should join?
Who should join?
Who should join?
This newsletter is relevant for anyone interested in the evolving landscape of G4 therapeutics and disease biology, including:
- Researchers in cancer, RNA biology, genomics, structural biology, and translational medicine
- Biotech and pharmaceutical professionals
- Clinicians and physician-scientists
- PhD students and postdoctoral fellows
Why join?
Who should join?
Who should join?
The field of the biology and chemistry of G4 is expanding rapidly across cancer research, RNA biology, genome stability, and therapeutic development. G4 Insights helps you stay up to date on the discoveries shaping the future of G4 biology and their real-world applications without spending hours filtering through publications and scattered updates. As the platform grows, members will also gain opportunities to engage with a broader community of researchers, clinicians, and industry professionals interested in the future of G4 science.
A diverse International G4 Community
G4 Insights is growing into a diverse international community united by a shared interest in G-quadruplex science. Our members bring perspectives from academia, biotechnology, industry, and therapeutic research, creating opportunities for knowledge exchange and meaningful collaboration.
Partner with G4 Insights
Why Partner with G4 Insights?
G4 Insights brings together researchers, clinicians, biotech innovators, and industry leaders focused on advances in G-quadruplex biology, disease mechanisms, and therapeutic development. Our platform is designed to connect cutting-edge science with the wider G4 research and innovation community.
Collaboration Opportunities
We welcome partnerships with research groups, biotechnology companies, scientific organizations, event organizers, and service providers working within or alongside the G4 field. Collaboration formats may include sponsored educational content, research and industry spotlights, event partnerships, expert interviews, and other tailored initiatives designed to engage a G4 specialist scientific audience.
Let’s Build Something Together
If you are interested in exploring a partnership with G4 Insights, we would be happy to discuss ideas that align with your goals and our scientific community. Contact us at g4insights@guaninemedical.com to start a conversation.
Frequently Asked Questions
If you cannot find your question and for any other inquires, please reach out to us at g4insights@guaninemedical.com
Joining is simple. Click on the "Join G4 Insights" link, provide your information and email address, and you will start receiving G4 Insights directly in your inbox.
G4 Insights brings together an international community of researchers, clinicians, graduate students, biotech innovators, industry professionals, and scientific communicators interested in G-quadruplex chemistry and biology. Our members work across areas such as molecular and structural biology, genomics, cancer research, genetic disease, RNA biology, drug discovery, therapeutic development, and biotechnology.
Yes. G4 Insights welcomes recently published studies relevant to G-quadruplex biology, disease mechanisms, translational science, and therapeutic development. Researchers are encouraged to share publications that align with the platform's scientific focus for potential inclusion in future highlights, news updates, or featured discussions. If you'd like your publications to be featured, send an email to g4insights@guaninemedical.com with a link and a brief summary of your publication.
Yes. G4 Insights is free to join.
G4 Insights is delivered biweekly on Tuesday mornings. Additional emails may occasionally be shared for important announcements, events, or major developments relevant to the G4 community. The G4 Insights Annual Report is delivered in January.
We welcome enquiries from biotechnology and pharmaceutical companies, research groups, universities, scientific organizations, event organizers, technology providers, and other groups whose work is relevant to the G4 community.
Partnerships may include sponsored educational content, industry or research spotlights, expert interviews, event promotion and coverage, newsletter sponsorship, educational videos, and tailored scientific communication initiatives.
Yes. We are happy to develop a partnership that aligns with your objectives while providing meaningful, scientifically relevant content for the G4 Insights community.
Yes. We are happy to develop a partnership that aligns with your objectives while providing meaningful, scientifically relevant content for the G4 Insights community. Every proposal is reviewed individually by the editorial team. Partnerships must align with the interests of the G4 community and meet our standards for scientific relevance and accuracy.
Yes. We can explore collaborations involving conferences, webinars, workshops, scientific meetings, and other relevant events. Opportunities may include event promotion, speaker interviews, educational summaries, or post-event coverage.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.